(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

GENEA BIOMEDX GERI

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

GENEA BIOMEDX GERI

ST13

US500000079172364

Class

9, 10

Filing

79172364

Registration

5029101

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

36

Latest update

08/31/2025

Trademark type

Combined

Nice classes

9, 10

Filing date

06/12/2015

Registration date

08/30/2016

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/08/2023

Last transaction

08/31/2025

Responsible office

United States Patent and Trademark Office

Status code

706

Official register

Principal Register

Drawing code

3

Owner type

99

Owner location

Sydney NSW 2000, AU

Examiner

MITTLER,ROBIN M

Law office

N10

Current location

GENERIC WEB UPDATE

Mark description

The mark consists of a square divided by a curved line, next to the stylized wording "GENEA BIOMEDX", which is above the larger stylized wording "GERI".

Holders and representatives

Holders

Genea IP Holdings Pty Ltd

Representatives

Eric Lamb Frost Brown Todd LLP

Technical classification

Nice Classes

Class 9Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 9

Scientific and laboratory apparatusinstruments and equipmentincubators and parts and fittings specially designed therefor used to support development of human embryoshuman reproductive tissuehuman spermhuman blastocysts or human oocytes and being for scientific use; apparatusinstruments and equipment for clinical and medical laboratory useincubators and parts and fittings specially designed therefor used to support development of human embryoshuman reproductive tissuehuman spermhuman blastocysts or human oocytes and being for laboratory use; laboratory equipment and suppliesincubators; laboratory equipment and suppliesincubators for scientific use; laboratory equipment and suppliesincubators for scientific and laboratory use in the fields of reproductive sciencehuman fertilityhuman reproduction and assisted conception

Class 10

Medical apparatusinstruments and equipmentincubators and parts and fittings specially designed therefor used to support development of human embryoshuman reproductive tissuehuman spermhuman blastocysts or human oocytes for in vitro fertilization or treatment of infertility and other disorders relating to fertility and human reproduction; incubators for medical purposes

Publications

History of USPTO decisions and trademark events.

36 publications found

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

08/30/2025

RNWL

INTERNATIONAL REGISTRATION RENEWED

07/03/2025

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

09/08/2023

71AG

REGISTERED-SEC.71 ACCEPTED

09/08/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/07/2023

ES71

TEAS SECTION 71 RECEIVED

02/20/2023

NREP

NEW REPRESENTATIVE AT IB RECEIVED

01/07/2022

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

08/30/2021

NREP

NEW REPRESENTATIVE AT IB RECEIVED

02/15/2019

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

01/18/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

01/18/2019

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

12/23/2016

FICS

FINAL DISPOSITION NOTICE SENT TO IB

12/01/2016

FIMP

FINAL DISPOSITION PROCESSED

12/01/2016

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

11/30/2016

R.PR

REGISTERED-PRINCIPAL REGISTER

08/30/2016

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

07/15/2016

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/14/2016

PUBO

PUBLISHED FOR OPPOSITION

06/14/2016

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

06/01/2016

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

06/01/2016

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/25/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/07/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/07/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/06/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/06/2016

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/23/2016

RFNT

REFUSAL PROCESSED BY IB

10/24/2015

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

10/08/2015

RFRR

REFUSAL PROCESSED BY MPU

10/08/2015

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

10/07/2015

CNRT

NON-FINAL ACTION WRITTEN

10/06/2015

DOCK

ASSIGNED TO EXAMINER

09/22/2015

MAFR

APPLICATION FILING RECEIPT MAILED

09/22/2015

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/18/2015

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

09/17/2015

Continuous trademark protection

Get notified about every new filing that threatens GENEA BIOMEDX GERI or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.